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tumors especially lung cancer which impact outcome. Post-treatment 
surveillance is therefore practiced on the premise that early detection 
and timely treatment of recurrences and second primary lung cancers 
(SPLC) could improve outcome. 
Objectives: To determine the outcome of curatively treated HNC 
patients referred because of the suspicion of SPLC. 
Methods: Between 1996 and 2005, patients with HNC referred for 
respiratory symptoms and/ or radiological abnormalities suspicious for 
lung cancer were evaluated with radiology and autoﬂuorescence bron-
choscopy. Data on patient demographics, smoking, pack years, cancer 
characteristics and outcome were collected and analyzed.
Results: Fifty-one patients (44 males) with curatively treated N0 
HNC were evaluated. Median age was 70 years (range, 63-79), all 
were current or former smokers of 35 pack years (range, 30-45) and 
25 had chronic obstructive lung disease. With a median follow up of 
60 months, 8 patients were diagnosed with synchronous and 26 with 
metachronous SPLC. A total of 42 SPLC were diagnosed; 12 (29%) in 
the central airways and 30 (71%) parenchymal. Median time to meta-
chronous SPLC was 24 months. Most of SPLC (38/42) were surgically 
resectable. Five occult cancers detected by AF bronchoscopy were 
successfully treated with endobronchial therapy. Lung cancer mortal-
ity was 24%. Survival of synchronous and metachronous SPLCs was 
signiﬁcantly shorter (83 and 144 months) compared to those with HNC 
alone (240 months) (p=0.002).
Conclusion: SPLC has a negative impact on the survival of patients 
with HNC. Close surveillance with autoﬂuorescence bronchoscopy and 
CT for SPLC combined with aggressive treatment of early stage lung 
cancer might be a strategy to improve outcome. 
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Background: Harbor Hospital is located in downtown Baltimore, 
serving largely blue-collar workers with very high smoking prevalence. 
Non-small cell lung cancer is the most common malignancy seen at 
this hospital, usually diagnosed at inoperable or metastatic stages. We 
pioneered low-cost and free chest CT scan program for this high risk 
population based on recent data indicating that yearly screening CT 
scans of chest can lead to early lung cancer diagnosis, and may reduce 
the lung cancer mortality.
Methods: Low cost screening chest CT scan was advertised through 
mass media and was offered to general population. We secured outside 
funding for approximately 300 free screening chest CT scans and these 
were offered through local primary care providers who were asked to 
identify individuals at high risk for lung cancer development based 
on their smoking and/or asbestos exposure history. Overall eligibility 
criteria for screening CT scan were age 55 and above, with at least 20 
pack-year smoking history. All CT scans were done at Harbor Hospital 
Radiology Department, and results were classiﬁed as negative, indeter-
minate or suspicious. Indeterminate or suspicious results were reviewed 
and discussed at the multidisciplinary Lung Tumor conference and 
follow-up recommendation was issued according to the Early Lung 
Cancer Action Program (ELCAP) guidelines.
Results: A total of 492 patients underwent screening chest CT scans 
between 3/2003 and 2/2006. Median age of patients was 57 years 
(33-80), with 261(53%) women and 231(47%) men. The majority of 
screened population was Caucasian (68%), with 20% African Ameri-
cans and small number of Asians (3%). More than 95% of the patients 
were current or ex-smokers, with median of 33-pack year smoking 
history (3-200). Among 459 smokers, 133 (29%) were former smokers 
with median of 10-year smoking cessation history (1mo to 40 years). 
Initial CT scan results were reported as normal in 258 (52%) and 
indeterminate in 234(48%). Non-small cell lung cancer was diagnosed 
in 8 patients (1.6%), who were referred to appropriate disciplines for 
staging and treatment. Three out of 8 patients were found to have stage 
I/II NSCLC and underwent surgical resection. Total of 10 out of 492 
patients were diagnosed with cancer, two additional patients were inci-
dentally found with other types of cancers, one laryngeal and another 
with pancreatic cancer. 
Conclusion: Eight cases of NSCLC were diagnosed after screen-
ing 492 high-risk populations at a community hospital in downtown 
Baltimore. Among them, three patients (38%) were found to have early 
stage lung cancer and were offered curative resection. Following our 
experience, many other local community hospitals engaged in similar 
programs to provide low cost chest CT scans for early lung cancer 
detection. In our limited experience, screening chest CT scans yielded 
relatively more early stage lung cancers than our historical control. 
The usefulness of this approach remains to be established with ongo-
ing large multicenter randomized trials sponsored by National Cancer 
Institute and ELCAP. 
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